20-Year study sheds light on rare breast tumor outcomes

NCT ID NCT07636096

Completed Knowledge-focused Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study reviewed medical records of about 3,500 patients with phyllodes tumors, a rare type of breast tumor, treated at 8 top hospitals in China between 2001 and 2023. Researchers aim to describe the tumor features, treatments used, and long-term outcomes like recurrence and survival. Because phyllodes tumors are uncommon and most prior research focused on Western patients, this study provides much-needed data from a large Asian population.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this study could improve understanding of phyllodes tumors in Asian populations and help guide personalized treatment and clinical guidelines.
What could go wrong: This is a retrospective study, not a controlled trial, so it cannot prove cause and effect. Results may not apply to other populations or change current practice.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREAST PHYLLODES TUMOR are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

breast phyllodes tumor malignant breast phyllodes tumor phyllodes tumor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PHYLLODES BREAST TUMOR PROGNOSIS

Contacts and locations

Locations

Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University

Guangzhou, Guangdong, 510120, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.